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ABSTRACT 
Background: No prior twin study has explored the heritability of clinically diagnosed ADHD. 
Such studies are needed to resolve conflicting results regarding the importance of genetic effects 
for ADHD in adults. We aimed to estimate the relative contribution of genetic and environmental 
influences for clinically diagnosed ADHD across the life-span with a specific focus on ADHD in 
adults.  
Method: Information about zygosity and sex was obtained from 59,514 twins born between 
1959 and 2001 included in the nation-wide population-based Swedish Twin Register. Clinical 
data of ADHD diagnosis was obtained from the Prescribed Drug (i.e., stimulant or non-stimulant 
medication for ADHD) and National Patient Registers (i.e., ICD-10 diagnosis of ADHD). Twin 
methods were applied to clinical data of ADHD diagnosis using structural equation modeling 
with monozygotic and dizygotic twins. 
Results: The best-fitting model revealed a high heritability of ADHD (0.88; 95% CI, 0.83-0.92) 
for the entire sample. Shared environmental effects, on the other hand, were non-significant and 
of minimal importance. The heritability of ADHD in adults was also substantial (0.72; 95% CI, 
0.56-0.84).  
Conclusion: This study showed that the heritability of clinically diagnosed ADHD is high across 
the life span. Our finding of high heritability for clinically diagnosed ADHD in adults indicate 
that the previous reports of low heritability is best explained by rater effects and that gene-
identification studies of ADHD in adults needs to consider pervasiveness (e.g., multiple raters) 
and developmentally (e.g., childhood onset criteria) informative data. 
 
Key words: ADHD; Twin study; heritability; Adults  
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INTRODUCTION 
Many twin studies have explored the heritable nature of Attention-Deficit Hyperactivity Disorder 
(ADHD), but none of these have been based on clinically diagnosed cases. Such a study is 
needed to clarify how genetic factors influence ADHD across different levels of severity, 
(Larsson et al 2012) and to resolve inconsistent results regarding the heritability of ADHD in 
adults (Franke et al., 2012).  
Twin studies using parent or teacher ratings of continuous trait measures indicate that 
ADHD is highly heritable (~60-90) (Burt, 2009, Nikolas and Burt, 2010, Faraone et al., 2005).  
The few available twin studies using categorical measures of ADHD (see Table 1) suggest 
equally high heritability estimates (Lichtenstein et al., 2010, Sherman et al., 1997, Thapar et al., 
2000, Larsson et al., 2011), but these studies suffer from clear limitations. In particular, they 
applied broad categories that contain milder cases which would not meet syndromal criteria for 
ADHD and all studies lacked information on the age of onset or impairment criteria used in the 
DSM and ICD diagnostic definition. Thus, more stringent diagnostic methods and narrow 
definitions may generate different heritability estimates. 
Twin studies suggest substantially lower heritability estimates (~30-40%) for ADHD in 
adults (Boomsma et al., 2010, Larsson et al., 2013, Reiersen et al., 2008, van den Berg et al., 
2006), but it has been difficult to resolve if the drop in heritability reflect true developmental 
changes or relate to rater effects (Franke et al., 2012) . This is because twin studies on ADHD in 
adults have used self-ratings, while studies on children have used informant ratings (i.e., parent 
and teacher ratings). The few studies on this topic suggest that the heritability of self-rated 
ADHD is low in both adults and adolescents (Kan et al., 2013, Merwood et al., 2013), and also 
that the heritability of ADHD in adults is substantial, when both self and parent ratings are 
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combined into a composite index of ADHD (Chang et al., 2013), which together indicate the low 
heritability for ADHD in adults is best explained by rater effects. Nevertheless, more rigorously 
characterized twin samples are desired, including clinically stringent measures of ADHD, to 
more firmly establish the heritability of ADHD in adults. 
In the present report we use data from 59,514 twins born between 1959 and 2001 
included in the Swedish Twin Register (Lichtenstein et al., 2006). Clinical data on ADHD from 
Swedish national registers was obtained. We aimed to estimate the relative contribution of 
genetic, shared environmental and non-shared environmental influences for clinically diagnosed 
ADHD across the life-span with a specific focus on ADHD in adults. Based on previously 
observed similarities between continuous trait measures and broad categorical definitions, we 
predict similar heritability estimates also for clinically diagnosed ADHD. Based on the recent 
cross-informant twin studies (Chang et al., 2013), we predict high heritability also for ADHD in 
adults. This is because both cross-informant measures and clinical diagnosis both focus on 
pervasive symptoms.  
METHODS 
SWEDISH TWIN REGISTER   
We obtained the data from the nationwide population-based Swedish Twin Register 
(Lichtenstein et al., 2006). The target population in this study were all twins born in Sweden 
between 1959 and 2001 (N=89,174). Excluded from the analyses were twin pairs with unknown 
zygosity (N=21,714), twin pairs in which one or both died (N=3,250) or emigrated (N=4,696) 
before the start of follow-up in 2001; thus, the final sample of 59,514 male twins (29,177 male 
twins, 49%) represented 67% of the targeted population. Twin analyses on ADHD in adults was 
based on a sub-sample of 37,714 twins (18,092 male twins, 48%) born 1959-1991. 
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Zygosity was established using DNA testing or standard zygosity questionnaires 
concerning twin similarity and confusion (Lichtenstein et al., 2006). When zygosity was 
determined based on questionnaire data, only twins with more than 95% probability of being 
correctly classified were assigned a zygosity. In the twin analyses, 17,026 were monozygotic 
(MZ), 16,554 were dizygotic (DZ), and 25,934 were opposite sex DZ twins.  
 
NATIONAL REGISTERS  
Data from the Swedish Twin Register was linked to the population based Prescribed Drug and 
Patient Registers, using each individual’s unique personal identification number.  
The Swedish Prescribed Drug Register (PDR) is a national healthcare register 
(administered by the National Board of Health and Welfare) with data on dispensed 
pharmaceuticals. Information regarding drug identity according to the Anatomical Therapeutic 
Chemical classification system, quantity and dosage of the prescribed drug, and date of 
prescription has been registered since July 2005. The register covers the entire population of 
Sweden, and the identity of the patients is available for > 99.7% of the population (Wettermark 
et al., 2007).  
The Patient Register (held by the National Board of Health and Welfare) has nationwide 
coverage for psychiatric outpatient care since 2001. Every record has a discharge date, a primary 
discharge diagnosis, and up to seven secondary diagnoses assigned by the treating medical 
doctor according to WHO’s International Classification of Diseases (ICD-10) (WHO, 1992).  
VARIABLES 
Twins treated with stimulant or non-stimulant medication for ADHD (methylphenidate 
[N06BA04]; atomoxetin [N06BA09]; amphetamine [N06BA01]; dexamphetamine [N06BA02]) 
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at any time between July 2005 and July 2010 were identified via PDR. National guidelines for 
medication of ADHD, issued by the National Board of Health and Welfare in 2002, stated that 
medication should be reserved for cases where other supportive interventions have failed, 
indicating that pharmacological ADHD treatment most likely represents an indicator of the more 
severe cases of ADHD. The authority to prescribe ADHD drugs in Sweden is restricted to 
specialist physicians familiar with the treatment of this disorder. In the total sample of 59,514 
twins, 730 (1.23%) were treated for ADHD/hyperkinetic disorder at any time between 2005 and 
2010.  
Twins obtaining a diagnosis of hyperkinetic disorder between 2001 and 2009 were 
identified via the Patient Register (ICD-10: F90). In the total sample of 59,514 twins, 525 
(0.88%) had received a diagnosis of hyperkinetic disorder from outpatient care  A substantial 
number of these twins (n=392, 74.7%) were treated with stimulant or non-stimulant medication 
at any time between 2005 and 2010.  
To maximize power in the twin model fitting analyses, the present study  applied an “or” 
approach to define clinically diagnosed ADHD resulting in 863 twins (1.45%) who either meet 
criteria for  hyperkinetic disorder at any time between 2001 and 2009 or have received stimulant 
or non-stimulant treatment at any time between 2005 and 2010. Twin model fitting on ADHD in 
adults was based on the sub-sample of 37,714 twins born between 1959 and 1991 (i.e., 18 years 
old or older at the end of follow-up) resulting in 241 (0.64%) twins with a clinical diagnosis of 
ADHD in adults; our definition only considered twins diagnosed  with ADHD at the age of 18 
years or older.  
The study was approved by the research ethics committee at Karolinska Institutet, 
Stockholm, Sweden. 
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STATISTICAL ANALYSES 
The concordance rate (i.e., the risk of ADHD for the cotwin of a twin with ADHD) was 
calculated as the proportion of individuals belonging to concordantly affected twin pairs out of 
all twins with the disorder. Correlation of liability (tetrachoric within-twin pair correlation) was 
also estimated for each zygosity group. Higher concordance rates and correlations of liability in 
MZ than in DZ twins indicate a genetic contribution to the manifestation of disease. Shared 
environmental influences were inferred if the DZ correlation was greater than half of the MZ 
correlation (the DZ correlation higher than expected from sharing 50% of their segregating 
genes).  
Biometric twin analyses were conducted on raw ordinal data using the Mx program 
(Neale, 2003) to determine the relative contribution of additive genetic factors (A, Heritability) 
reflecting additive effects of different alleles, shared environmental factors (C) reflecting 
environmental influences that make twin siblings similar to each other and non-shared 
environmental factors (E) reflecting non-genetic influences that make twin pairs dissimilar 
(Rijsdijk and Sham, 2002). In twin models based on ordinal raw data, each individual is coded as 
having the disease or not, and the threshold (z score) corresponds to the rate of the disease.  
The following combinations of variance components were considered in the twin models: 
ACE and AE. Three sex-limitation models were fitted to the data. The full sex-limitation model 
allows quantitative and qualitative differences in the parameter estimates between males and 
females. The common effects sex-limitation model allows quantitative sex differences between 
males and females, but no qualitative differences. The null model equates all genetic and 
environmental parameter estimates for males and females, testing the hypothesis. Goodness of fit 
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for the different twin models was assessed by Akaike’s Information Criterion (AIC); a lower 
AIC value indicates better fit of the model to the observed data. 
The quantitative genetic models were performed under the usual assumptions of the 
classical twin designs: random mating, no gene–environment interaction, and equal 
environments of MZ and DZ twin pairs (Rijsdijk and Sham, 2002).  
 
RESULTS 
We used available psychiatric symptom data from a study of twins born between 1992 
and 2001 to explore the validity of the register-based ADHD diagnosis. ADHD symptoms in 
twins were assessed using the Autism – Tics, ADHD, and other Comorbidities inventory (A-
TAC), which covers 96 specific child psychiatric symptoms, for which two studies with 
extensive psychometric analyses have shown excellent validity for the ADHD-measures 
(Hansson et al., 2005, Larson et al., 2010). The mean ADHD score of the twins with our register-
based definition of ADHD (m=9.05, SD=5.32) was substantially higher (Cohen's d = 1.74) than 
the total sample mean of 1.73 (SD=2.68). In addition, about 70% of the twins with an ADHD 
diagnosis were identified as screen-positive for parent-rated ADHD. Very similar results were 
obtained when these validity checks were restricted to either ADHD cases identified through 
ICD diagnoses (i.e., Patient Register) or pharmacological ADHD treatments (i.e., Prescribed 
Drug Register). 
Concordance rates and tetrachoric correlations for the full sample (59,514 twins born 1959-
2001) are shown in Table 2. Tetrachoric DZ correlations were half of the MZ correlations, 
suggesting genetic, but not shared environmental influences on ADHD. MZ correlations were 
less than 1, suggesting non-shared environmental influences (including measurement error). 
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Tetrachoric twin correlations were similar for males and females, which suggest no quantitative 
sex-differences in the genetic and environmental contribution. In addition, twin correlations were 
similar for same-sexed DZ and DZOS twins, which suggest no qualitative sex-differences (Table 
2). 
Table 3 displays the age-adjusted model fitting results of ACE and AE sex-limitation models 
compared to the saturated model using the full twin sample (59,514 twins born 1959-2001). In 
all these models, thresholds were equated across twin 1 and twin 2, for MZ and DZ twins, but 
not across males (z score, 1.46; corresponds to a prevalence rate of X.X%) and females (z score, 
2.06; corresponds to a prevalence rate of Y.Y%). As can be seen, the AE null model had the 
lowest AIC value. That is, a model that constrained the genetic and environmental parameter 
estimates to be equal across sex, and excluded variance in liability due to the shared 
environmental factor provided the most parsimonious fit of the data. This best-fitting model 
estimated the heritability and non-shared environment contribution as 0.88 (95% CI, 0.83-0.92) 
and 0.12 (95% CI, 0.08-0.17), respectively.  
Similar results were obtained when refitting all twin models using an “AND” approach (i.e., 
clinically diagnosed ADHD defined as meeting criteria for hyperkinetic disorder and received 
stimulant/non-stimulant treatment). The best fitting model (AE null model) estimated the 
heritability and non-shared environment contribution as 0.89 (95% CI, 0.82-0.94) and 0.11 (95% 
CI, 0.06-0.18), respectively. Similar genetic and environmental parameter estimates were also 
obtained when the twin modeling were restricted to either ADHD cases identified through ICD 
diagnoses (A=0.89; 95% CI, 0.83-0.93; E=0.11; 95% CI, 0.07-0.17) or pharmacological ADHD 
treatments (A=0.88; 95% CI, 0.83-0.92; E=0.12; 95% CI, 0.08-0.17), providing converging 
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evidence across different outcome definitions Table 3. Genetic and non-shared environmental 
parameter estimates from best-fitting model.  
Heritability of ADHD in adults 
Analyses were also conducted on twins born between 1959 and 1991 (N=37,714 twins) 
to estimate the heritability of ADHD in adults. These twins were on average 23.0 years old at the 
start of the register follow-up.  Importantly, we only considered twins diagnosed with ADHD at 
the age of 18 years or older.The best fitting model (AE null model) estimated the heritability and 
non-shared environment contribution as 0.72 (95% CI, 0.56-0.84) and 0.28 (95% CI, 0.16-0.44), 
respectively. 
DISCUSSION 
This study showed that the heritability of clinically diagnosed ADHD is high across the life span. 
The study findings are important for ongoing discussion about ADHD as a categorical disorder 
versus an extreme of a continuous trait (Thapar and Lewis, 2009). In addition, our finding of 
high heritability for clinically diagnosed ADHD in adults indicate that the previous reports of 
low heritability is best explained by rater effects and that gene-identification studies of ADHD in 
adults needs to consider pervasiveness (e.g., multiple raters) and developmentally (e.g., 
childhood onset criteria) informative data.     
In this study, using data from representative national registers, we estimated the 
heritability of clinically diagnosed ADHD at 88%. Our result is in line with the large number of  
twin studies using continuous trait measures of ADHD based on parent or teacher ratings (Burt, 
2009, Faraone et al., 2005), and the few studies that have explored the genetic impact on 
categorically defined ADHD (Lichtenstein et al., 2010, Sherman et al., 1997, Thapar et al., 2000, 
Larsson et al., 2011). There are noteworthy differences between the present study and these prior 
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twin studies, in particular related to differing assessment methodologies. In the present study 
subjects were diagnosed with ICD-10. These diagnoses are performed by clinicians, and thus 
based on structured interviews covering age of onset of the impairing symptoms and presence of 
impairment in multiple settings, while prior twin studies were based on quantitative measures of 
ADHD symptoms without addressing the childhood criteria and not systematically assessing the 
impairment in multiple settings criteria. Yet, remarkably similar heritability estimates for ADHD 
were obtained across studies suggesting strong genetic effects in ADHD regardless of whether it 
is assessed using continuous trait measures, broad categorical definitions or narrow diagnostic 
definitions, which in turn provides further support for ADHD as a quantitative extreme of 
genetic and environmental factors operating dimensionally throughout the distribution of ADHD 
symptoms (Chen et al., 2008, Larsson et al., 2012, Levy et al., 1997).  
One novel finding of this study was that clinically diagnosed ADHD in adults was highly 
heritable. The finding is in line with a recent cross-informant twin study reporting that the 
heritability of ADHD in 19–20 year olds was 78%, when both self and parent ratings were 
combined into a composite index of ADHD symptoms to adjust for rater bias (Chang et al., 
2013) and also with prior family studies suggesting a high familial loading on ADHD in adults 
(Biederman et al., 1996, Biederman et al., 1995, Faraone et al., 2000, Faraone, 2004), but is 
inconsistent with what has been reported in twin studies of self-rated ADHD in adults (Reiersen 
et al., 2008, Boomsma et al., 2010, van den Berg et al., 2006, Larsson et al., 2013). One 
increasingly recognized explanation to previous reports of low heritability for ADHD in adults is 
increased contribution of measurement error (reflecting accuracy of the measures) associated 
with the use of self-ratings (Kan et al., 2013, Franke et al., 2012, Merwood et al., 2013, Chang et 
al., 2013). Another explanation is that the clinical diagnosis of ADHD in adults reflects 
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persistence of the childhood disorder (i.e., childhood onset), whereas cross-sectional self-ratings 
may also reflect adult-onset ADHD-like symptoms (i.e., phenocopies) involving different genetic 
and environmental processes. Taken together, this indicates that self-ratings may not be the best 
measure to use in gene-identification studies of ADHD in adults and that other factors such as 
childhood onset, pervasiveness and impairment should be taken into account. 
Limitations 
This study had some limitations. First, it was not possible to classify ADHD cases according to 
the three DSM-IV ADHD subtypes (i.e., combined, primarily hyperactive-impulsive and 
primarily inattentive type), since these were not recorded across the registers. However, prior 
twin research suggests similar heritability estimates for the inattentive and hyperactive-impulsive 
component of ADHD (Nikolas and Burt, 2010, Larsson et al., 2006).     
Second, the validity of the non-standardized register diagnoses has not been explored  
using comparisons with research diagnoses based on independent semi-structured interviews 
and/or medical records. Even though our own validity checks of ADHD support high specificity 
for the register-based diagnosis, we could not rule out false negatives (i.e., individuals with 
ADHD who had never been recorded in any registers). This is because the Patient Register 
provided coverage of outpatient care after 2001 and the Swedish Prescribed Drug Register 
provided data on twins treated with stimulant or non-stimulant medication after 2005. However, 
bias due to such outcome miss-classification most probably applies equally to MZ and DZ pairs 
and would therefore not introduce a significant upward bias of the heritability estimate.   
Third, the ascertainment of ADHD cases was predominantly based on ICD-10 diagnosis 
of hyperkinetic disorder and prescribed medication unique for the treatment of ADHD. The ICD-
10 definition of ADHD is stricter compared with that in DSM-IV, and National guidelines for 
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medication of ADHD, issued by the Swedish National Board of health and Welfare in 2002, 
stated that medication should be reserved for cases where other supportive interventions have 
failed, indicating that our measure most likely represent an indicator of the more severe cases of 
ADHD.  Thus, generalizations should be made with caution. 
Fourth, even with a nationwide twin cohort born 1959-2001 the absolute numbers of 
clinically diagnosed concordant or discordant twin pairs remained limited, resulting in wide 
confidence intervals and limited power to detect shared environmental influences. Point 
estimates, especially for ADHD in adults, should therefore be interpreted with caution. 
Conclusions  
We have demonstrated that heritability estimates for clinically diagnosed ADHD is high across 
the life span. This indicates that the previous reports of low heritability for ADHD symptoms in 
adults are best explained by rater effects giving rise to measurement error, rather than by distinct 
developmental changes in the importance of non-shared environmental factors. 
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Table 1.  Twin studies using exploring the heritability using categorical measures of ADHD.  
   
Authors 
Twin sample Measure  Informant % meeting cut-off 
criteria for ADHD 
Heritability 
 
Larsson et al 2011 
 
Population: 
children/adolescents; 
1,450 twin pairs;  aged 
8-17 years; Swedish  
 
Longitudinal  
DSM-IV ADHD 
symptoms 
 
Parents 
 
i. High trajectory of 
Hyperactivity 
ii. High trajectory 
of inattention  
 
i. 80% 
ii. 72% 
 
Lichtenstein et al 2010 
 
Population: 10,895 
twin pairs; aged 12 
years; Swedish   
 
DSM-IV ADHD 
symptoms 
 
Parents 
 
1.8% 
 
79% 
 
Sherman et al 1997 
 
Population: 288 twin 
pairs; aged 11-12 
years; USA   
 
DSM-III-R 
ADHD symptoms 
 
Teachers and 
parents, combined 
18% 79% 
 
Thapar et al 2000 
 
Population: 2,082 twin 
pairs; aged 11-12 
years; UK  
  
 
DSM-IV ADHD 
symptoms 
 
Teachers and 
parents, combined 
 
- 
 
80% 
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Table 2. Concordance rates and tetrachoric correlations with 95% confidence intervals (95% CI) for clinical diagnosis of ADHD in 
59,514 Swedish twins, by Sex and Zygosity 
   Opposite-sex twins 
   MZM DZM MZF DZF Case=Male Case=Female 
Clinical diagnosis of ADHD       
  No. of concordant affected pairs 35 13 11 5 29 29 
  No. discordant pairs 55 139 38 68 277 100 
  Concordance rates  
  (95% CI) 
0.56 
(0.45-0.66) 
0.16 
(0.09-0.25) 
0.37 
(0.21-0.54) 
0.13 
(0.04-0.26) 
0.17 
(0.12-0.24)
0.37 
(0.27-0.47) 
  Tetrachoric correlations  
  (95% CI) 
0.90 
(0.84-0.94) 
0.48 
(0.33-0.61) 
0.81 
(0.68-0.90) 
0.50 
(0.28-0.67) 
0.49 
(0.40-0.58) 
 MZM, monozygotic male; MZF, monozygotic female; DZM, dizygotic male; DZF, dizygotic female. 
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Table 3. Model fitting results of univariate analysis of ADHD.   
 Fit of model compared to saturated model 
Model -2LL df χ2
 
Δdf AIC 
 
Saturated model 8092.5 59489 - - - 
1. ACE Univariate       
    Full sex-limitation modela 8112.0 59505 19.5 16 -12.5 
    Common effects sex-limitation model b 8112.0 59506 19.5 17 -14.5 
    Null modelc   8113.5 59509 21.0 20 -19.0 
2. AE Univariate      
    Full sex-limitation modela 8112.5 59507 20.0 18 -16.0 
    Common effects sex-limitation model b 8112.5 59508 20.0 19 -18.0 
    Null modelc   8113.7 59510 21.3 21 -20.7 
Best-fitting model indicated in bold. -2LL, likelihood fit statistic; df, degrees of freedom; χ2, the difference in -2LL between the 
saturated and restricted model; ∆df, difference in df between the saturated and restricted model; AIC, Akaike’s Information Criterion; 
a The full sex-limitation model allows quantitative and qualitative differences in the parameter estimates between males and females; 
bThe common effects sex-limitation model allows quantitative sex differences between males and females, but no qualitative 
differences; cThe null model equates all genetic and environmental parameter estimates for males and females, testing the hypothesis 
that there are no sex differences 
 
 
 
 
 
